Marissa Brittenham, Chief Strategy Officer at Surgery Partners, Inc. (SGRY), sold 3,657 shares at $12.54 ($46K) on 2026-03-13, disclosed to the SEC on 2026-03-16.
Seasonal sale ($46k) by Chief Strategy Officer — this insider has traded SGRY in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| SGRY | SELL | 2025-02-10 | $376K | — | Filing → |
| SGRY | SELL | 2024-03-06 | $39K | — | Filing → |
| SGRY | SELL | 2024-02-06 | $104K | — | Filing → |